Predictive Oncology Inc logo

Predictive Oncology Inc

1
NAS:POAI (USA)  
$ 3.42 -0.09 (-2.56%) 10:08 PM EST
At Loss
P/B:
1.18
Market Cap:
$ 13.90M
Enterprise V:
$ 5.14M
Volume:
16.39K
Avg Vol (2M):
19.05K
Also Trade In:
Volume:
16.39K
At Loss
Avg Vol (2M):
19.05K

Business Description

Description
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.
Name Current Vs Industry Vs History
Cash-To-Debt 3.77
Equity-to-Asset 0.64
Debt-to-Equity 0.27
Debt-to-EBITDA -0.23
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -14.01
Distress
Grey
Safe
Beneish M-Score -3.29
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.76
9-Day RSI 60.78
14-Day RSI 58.83
6-1 Month Momentum % -26.79
12-1 Month Momentum % -62.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.24
Quick Ratio 3.14
Cash Ratio 2.86
Days Inventory 289.03
Days Sales Outstanding 77.32
Days Payable 738.79

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -168.8
Shareholder Yield % -12.57

Financials (Next Earnings Date:2024-05-15 Est.)

POAI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:POAI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Predictive Oncology Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.808
EPS (TTM) ($) -4.67
Beta 1.53
Volatility % 95.19
14-Day RSI 58.83
14-Day ATR ($) 0.209588
20-Day SMA ($) 3.136005
12-1 Month Momentum % -62.53
52-Week Range ($) 2.47 - 13.88
Shares Outstanding (Mil) 4.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Predictive Oncology Inc Filings

Filing Date Document Date Form
No Filing Data

Predictive Oncology Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Predictive Oncology Inc Frequently Asked Questions

What is Predictive Oncology Inc(POAI)'s stock price today?
The current price of POAI is $3.42. The 52 week high of POAI is $13.88 and 52 week low is $2.47.
When is next earnings date of Predictive Oncology Inc(POAI)?
The next earnings date of Predictive Oncology Inc(POAI) is 2024-05-15 Est..
Does Predictive Oncology Inc(POAI) pay dividends? If so, how much?
Predictive Oncology Inc(POAI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1